Pregnancy outcomes in women using inhaled fluticasone during pregnancy: A case series

Allergologia et Immunopathologia

Volumn 35, Issue 6, 2007, Pages 239-242

  Choi, J S ^a   Han, Jung Yeol ^a,d   Kim, M Y ^a   Velazquez Armenta E Y ^b   Nava Ocampo, A A ^b,c  

^a Kwandong University College of Medicine   (South Korea)

^b PharmaReasons   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Cheil General Hospital   (South Korea)

Author keywords

Aerosol drug therapy; Fetal development; Fluticasone; Pregnancy; Teratology

Indexed keywords

FLUTICASONE;

ABORTION; ARTICLE; CONGENITAL MALFORMATION; DEMOGRAPHY; FETUS OUTCOME; FOLLOW UP; HUMAN; LIVE BIRTH; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURITY; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; TERATOGENICITY;

EID: 37249009079     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1157/13112989     Document Type: Article

References (16)

1. Hanania NA, Belfort MA. Acute asthma in pregnancy. Crit Care Med. 2005;33:S319-24.
2. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg L, Olsen J, Sorensen HT. Drug use in the first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol. 1999;55:139-44.
3. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review. Hum Exp Toxicol. 2006;25:447-52.
4. Blais L, Beauchesne MF, Rey E, Malo JL, Forget A. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax. 2007;62:320-8.
5. Kaliner MA. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: a comparison of ciclesonide and fluticasone propionate. Clin Ther. 2006;28: 319-31.
6. Masoli M, Weatherall M, Holt S, Shirtcliffe P, Beasley R. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis. Eur Respir J. 2006; 28:960-7.
7. Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol. 1998;92:435-40.
8. Olesen C, Thrane N, Nielsen GL, Sorensen HT, Olsen J, the EuroMAP group. A population-based prescription study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes. Respiration. 2001; 68:256-61.
9. Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol. 2003;102:739-52.
10. Schatz M, Dombrowski MP, Wise R, Momirova V, Landon M, Mabie W, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol. 2004;113:1040-5.
11. Enriquez R, Wu P, Griffin MR, Gebretsadik T, Shintani A, Mitchel E, et al. Cessation of asthma medication in early pregnancy. Am J Obstet Gynecol. 2006;195:149-53.
12. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1997;56:335-40.
13. Edwards MJ, Agho K, Attia J, Diaz P, Hayes T, Illingworth A, et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet A. 2003;120:459-63.
14. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92.
15. Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A, Mastroiacovo P, et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003;67:968-70.
16. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004; 18:93-101.